Rheumatologists Have an Important Role in the Management of Interstitial Lung Disease: A Cross-Specialty, Multi-Center, UK Perspective

The document discussed the critical role of rheumatologists in managing interstitial lung disease (ILD), particularly in collaboration with respiratory physicians. ILD, often associated with systemic autoimmune connective tissue diseases (CTD), posed significant diagnostic and management challenges. The study emphasized the importance of a multidisciplinary team (MDT) approach, involving both rheumatologists and respiratory specialists, to improve patient outcomes. Despite advancements in managing systemic sclerosis-associated ILD, progress in other autoimmune ILDs was slow, highlighting the need for better cross-specialty communication and shared decision-making. The document also addressed controversies, such as methotrexate-induced ILD, and the necessity for systematic approaches to optimize diagnosis and treatment. Collaborative efforts were deemed essential for advancing research, understanding disease mechanisms, and developing effective therapies for autoimmune ILD.